Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 802-810

  Climent, Yanet ^a,b   Yero, Daniel ^a,b   Martinez, Isabel ^a   Martín, Alejandro ^b   Jolley, Keith A ^c   Sotolongo, Franklin ^a   Maiden, Martin C J ^c   Urwin, Rachel ^c,d   Pajón, Rolando ^b,e  

^a FINLAY INSTITUTE   (Cuba)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD GROUP TYPING; CONTROLLED STUDY; CUBA; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; BACTERIAL TYPING TECHNIQUES; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CUBA; DNA FINGERPRINTING; DNA, BACTERIAL; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MOLECULAR EPIDEMIOLOGY; NEISSERIA MENINGITIDIS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

NEISSERIA MENINGITIDIS;

EID: 77749286971     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01653-09     Document Type: Article

References (55)

1. Abdillahi, H., and J. T. Poolman. 1988. Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies. FEMS Microbiol. Immunol. 1:139-144.
2. Abdillahi, H., and J. T. Poolman. 1988. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J. Med. Microbiol. 26:177-180.
3. Baethgen, L. F., L. Weidlich, C. Moraes, C. Klein, L. S. Nunes, P. I. Cafrune, A. P. Lemos, S. S. Rios, M. F. Abreu, C. Kmetzsch, A. F. Sperb, L. W. Riley, M. L. Rossetti, and A. Zaha. 2008. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing. Trop. Med. Int. Health 13:31-40.
4. Brehony, C., K. A. Jolley, and M. C. Maiden. 2007. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol. Rev. 31:15-26.
5. Buckee, C. O., K. A. Jolley, M. Recker, B. Penman, P. Kriz, S. Gupta, and M. C. Maiden. 2008. Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proc. Natl. Acad. Sci. U. S. A. 105:15082-15087.
6. Caugant, D. A., P. Bol, E. A. Hoiby, H. C. Zanen, and L. O. Froholm. 1990. Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. J. Infect. Dis. 162:867-874.
7. Caugant, D. A., B. E. Kristiansen, L. O. Froholm, K. Bovre, and R. K. Selander. 1988. Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect. Immun. 56:2060-2068.
8. Caugant, D. A., L. F. Mocca, C. E. Frasch, L. O. Froholm, W. D. Zollinger, and R. K. Selander. 1987. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J. Bacteriol. 169:2781-2792.
9. Caugant, D. A., G. Tzanakaki, and P. Kriz. 2007. Lessons from meningo-coccal carriage studies. FEMS Microbiol. Rev. 31:52-63.
10. Chiou, C. S., J. C. Liao, T. L. Liao, C. C. Li, C. Y. Chou, H. L. Chang, S. M. Yao, and Y. S. Lee. 2006. Molecular epidemiology and emergence of world-wide epidemic clones of Neisseria meningitidis in Taiwan. BMC Infect. Dis. 6:25.
11. Clarke, S. C., M. A. Diggle, and G. F. Edwards. 2001. Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis. J. Clin. Microbiol. 39:3066-3071.
12. Claus, H., M. C. Maiden, R. Maag, M. Frosch, and U. Vogel. 2002. Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148:1813-1819.
13. de Filippis, I., and A. C. Vicente. 2005. Multilocus sequence typing and repetitive element-based polymerase chain reaction analysis of Neisseria meningitidis isolates in Brazil reveal the emergence of 11 new sequence types genetically related to the ST-32 and ST-41/44 complexes and high prevalence of strains related to hypervirulent lineages. Diagn. Microbiol. Infect. Dis. 53:161-167.
14. de Moraes, J. C., B. A. Perkins, M. C. Camargo, N. T. Hidalgo, H. A. Barbosa, C. T. Sacchi, I. M. Landgraf, V. L. Gattas, H. G. Vasconcelos, B. D. Plikaytis, J. D. Wenger, and C. V. Broome. 1992. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340:1074-1078.
15. Devoy, A. F., K. H. Dyet, and D. R. Martin. 2005. Stability of PorA during a meningococcal disease epidemic. J. Clin. Microbiol. 43:832-837.
16. Dickinson, F. O., and A. E. Perez. 2005. Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system. BMC Infect. Dis. 5:103.
17. Dyet, K. H., and D. R. Martin. 2006. Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic. Epidemiol. Infect. 134:377-383.
18. Feil, E. J., B. C. Li, D. M. Aanensen, W. P. Hanage, and B. G. Spratt. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530.
19. Frasch, C. E., W. D. Zollinger, and J. T. Poolman. 1985. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7:504-510.
20. Huson, D. H., and D. Bryant. 2006. Application of phylogenetic networks in evolutionary studies. Mol. Biol. Evol. 23:254-267.
21. Jodar, L., I. M. Feavers, D. Salisbury, and D. M. Granoff. 2002. Development of vaccines against meningococcal disease. Lancet 359:1499-1508.
22. Jolley, K. A., C. Brehony, and M. C. Maiden. 2007. Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol. Rev. 31:89-96.
23. Jolley, K. A., E. J. Feil, M. S. Chan, and M. C. Maiden. 2001. Sequence type analysis and recombinational tests (START). Bioinformatics 17:1230-1231.
24. Jolley, K. A., J. Kalmusova, E. J. Feil, S. Gupta, M. Musilek, P. Kriz, and M. C. Maiden. 2000. Carried meningococci in the Czech Republic: a diverse recombining population. J. Clin. Microbiol. 38:4492-4498.
25. Kumar, S., K. Tamura, and M. Nei. 2004. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5:150-163.
26. Lancellotti, M., A. Guiyoule, C. Ruckly, E. Hong, J. M. Alonso, and M. K. Taha. 2006. Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex. Microbes Infect. 8:191-196.
27. Lewis, S., M. Sadarangani, J. C. Hoe, and A. J. Pollard. 2009. Challenges and progress in the development of a serogroup B meningococcal vaccine. Expert. Rev. Vaccines 8:729-745.
28. Maiden, M. C., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q. Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and B. G. Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U. S. A. 95:3140-3145.
29. Maiden, M. C., A. B. Ibarz-Pavon, R. Urwin, S. J. Gray, N. J. Andrews, S. C. Clarke, A. M. Walker, M. R. Evans, J. S. Kroll, K. R. Neal, D. A. Ala'Aldeen, D. W. Crook, K. Cann, S. Harrison, R. Cunningham, D. Baxter, E. Kaczmarski, J. MacLennan, J. C. Cameron, and J. M. Stuart. 2008. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis. 197:737-743.
30. Martinez, I., O. Lopez, F. Sotolongo, M. Mirabal, and A. Bencomo. 2003. Carriers of Neisseria meningitidis among children from a primary school. Rev. Cubana Med. Trop. 55:162-168. (In Spanish.)
31. Martínez, I., G. Sierra, N. Nuñez, L. Izquierdo, Y. Climent, and M. Mirabal. 2006. Characterization of Neisseria meningitidis strains isolated from carriers in Cuba during 20 years. Rev. Cubana Med. Trop. 58:8-17. (In Spanish.)
32. Milagres, L. G., M. C. Gorla, C. T. Sacchi, and M. M. Rodrigues. 1998. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine. Infect. Immun. 66:4755-4761.
33. Milagres, L. G., S. R. Ramos, C. T. Sacchi, C. E. Melles, V. S. Vieira, H. Sato, G. S. Brito, J. C. Moraes, and C. E. Frasch. 1994. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62:4419-4424.
34. MINSAP. 2008. Incidence and mortality of meningococcal disease 1980-2008. Anuario Estadístico de Salud de Cuba. http://www.sld.cu/ servicios/estadisticas/. (In Spanish.)
35. Morley, S. L., M. J. Cole, C. A. Ison, M. A. Camaraza, F. Sotolongo, N. Anwar, I. Cuevas, M. Carbonero, H. C. Campa, G. Sierra, and M. Levin. 2001. Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants. Pediatr. Infect. Dis. J. 20:1054-1061.
36. Murphy, K. M., K. A. O'Donnell, A. B. Higgins, C. O'Neill, and M. T. Cafferkey. 2003. Irish strains of Neisseria meningitidis: characterisation using multilocus sequence typing. Br. J. Biomed. Sci. 60:204-209.
37. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
38. Noronha, C. P., C. J. Struchiner, and M. E. Halloran. 1995. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. Int. J. Epidemiol. 24:1050-1057.
39. Oster, P., D. Lennon, J. O'Hallahan, K. Mulholland, S. Reid, and D. Martin. 2005. MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 23:2191-2196.
40. Perez, A., and F. Dickinson. 1998. Results of the meningococcal BC National Immunization Program in Cuba in children under 1 year of age. Rev. Cubana. Pediatr. 70:133-140. (In Spanish.)
41. Rodriguez, A. P., F. Dickinson, A. Baly, and R. Martinez. 1999. The epidemiological impact of antimeningococcal B vaccination in Cuba. Mem. Inst. Oswaldo Cruz 94:433-440.
42. Rosenstein, N. E., B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes. 2001. Meningococcal disease. N. Engl. J. Med. 344:1378-1388.
43. Scholten, R. J., J. T. Poolman, H. A. Valkenburg, H. A. Bijlmer, J. Dankert, and D. A. Caugant. 1994. Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990. J. Infect. Dis. 169:673-676.
44. Selander, R. K., D. A. Caugant, H. Ochman, J. M. Musser, M. N. Gilmour, and T. S. Whittam. 1986. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl. Environ. Microbiol. 51:873-884.
45. Sierra, G. V., H. C. Campa, N. M. Varcacel, I. L. Garcia, P. L. Izquierdo, P. F. Sotolongo, G. V. Casanueva, C. O. Rico, C. R. Rodriguez, and M. H. Terry. 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207.
46. Sotolongo, F., C. Campa, G. V. Casanueva, E. M. Fajardo, I. Cuevas, and N. Gonzalez. 2007. Cuban meningococcal BC vaccine: experiences & contributions from 20 years of application. MEDICC Rev. 9:16-22.
47. Takahashi, H., T. Kuroki, Y. Watanabe, H. Tanaka, H. Inouye, S. Yamai, and H. Watanabe. 2004. Characterization of Neisseria meningitidis isolates collected from 1974 to 2003 in Japan by multilocus sequence typing. J. Med. Microbiol. 53:657-662.
48. Tzanakaki, G., R. Urwin, M. Musilek, P. Kriz, J. Kremastinou, A. Pangalis, C. C. Blackwell, and M. C. Maiden. 2001. Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts. J. Clin. Microbiol. 39:1235-1240.
49. Urwin, R., and M. C. Maiden. 2003. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 11:479-487.
50. Urwin, R., J. E. Russell, E. A. Thompson, E. C. Holmes, I. M. Feavers, and M. C. Maiden. 2004. Distribution of surface protein variants among hyper-invasive meningococci: implications for vaccine design. Infect. Immun. 72:5955-5962.
51. Vogel, U., H. Claus, M. Frosch, and D. A. Caugant. 2000. Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J. Clin. Microbiol. 38:941-942.
52. Vogel, U., and M. Frosch. 1999. Mechanisms of neisserial serum resistance. Mol. Microbiol. 32:1133-1139.
53. Wyle, F. A., M. S. Artenstein, B. L. Brandt, E. C. Tramont, D. L. Kasper, P. L. Altieri, S. L. Berman, and J. P. Lowenthal. 1972. Immunologic response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126:514-521.
54. Yang, L., Z. Shao, X. Zhang, L. Xu, J. Peng, X. Xu, X. Liang, Y. Qi, and Q. Jin. 2008. Genotypic characterization of Neisseria meningitidis serogroup B strains circulating in China. J. Infect. 56:211-218.
55. Yazdankhah, S. P., P. Kriz, G. Tzanakaki, J. Kremastinou, J. Kalmusova, M. Musilek, T. Alvestad, K. A. Jolley, D. J. Wilson, N. D. McCarthy, D. A. Caugant, and M. C. Maiden. 2004. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J. Clin. Microbiol. 42:5146-5153.